Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis
Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Ischemic Preconditioning
Placebo
- Sham Intervention
What it measured
Main measures
Ability to tolerate Ischaemic Preconditioning (IPC_
One day
Safety
Other measures (1)
Perceived rate of exertion
One day
Walking and mobility
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
1. Diagnosis of MS as per the McDonald's criteria 2. Aged 18 or older 3. Sufficient cognitive ability to give informed consent 4. Ability to walk for 6 minutes without rest 5. Resting Systolic BP of less than 170 mmHg
Exclusion criteria
1. Cognitive difficulties in giving consent ad understanding the questionnaire 2. Inability to walk 3. Other systemic illness affecting exercise tolerance 4. Resting systolic BP of 170mmHg or more
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Regular physical activity improves aspects such as physical fitness, fatigue, quality of life, gait and also reduces the rate of progression of disability in individuals with Multiple Sclerosis. However, individuals with multiple sclerosis are less physically active than the general population. The determinants of engaging in physical activity for individuals with multiple sclerosis include psychological factors like motivation, self-belief and self-regulatory constructs and physical factors like fatigue, weakness, pain and ataxia. Ischemic preconditioning is exposure of the body to brief periods of circulatory occlusion and re-perfusion to protect organs against ischemic injury. Recent studies have also shown that ischemic preconditioning also improves exercise performance in healthy participants. The primary aim and objective of this study is to see whether it is feasible to use Ischemic preconditioning to improve exercise performance in people with Multiple Sclerosis. The design for the study is a double blind randomized control trial. Forty patients with multiple sclerosis above 18 years of age and who have the ability to walk will be randomized to receive either Ischemic preconditioning or sham intervention. All participants will be identified by MS consultants and nurses from the MS clinic and Neuro Day Case Unit of the Royal Hallamshire Hospital in Sheffield. Participation will involve an additional 2 hours of the patients time.
Papers
Loading reviews and guidelines…
History
Started
Apr 2017
Main results due
Dec 2019
Finished
Dec 2019